Log in

Relevant bibliographies by topics / Social anxiety disorder / Journal articles

To see the other types of publications on this topic, follow the link: Social anxiety disorder.

Journal articles on the topic 'Social anxiety disorder'

Author: Grafiati

Published: 4 June 2021

Last updated: 26 July 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Social anxiety disorder.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Morrison, Amanda S., and Richard G. Heimberg. "Social Anxiety and Social Anxiety Disorder." Annual Review of Clinical Psychology 9, no. 1 (March 28, 2013): 249–74. http://dx.doi.org/10.1146/annurev-clinpsy-050212-185631.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Seedat, S. "Social Anxiety Disorder." South African Journal of Psychiatry 19, no. 3 (August 30, 2013): 5. http://dx.doi.org/10.4102/sajpsychiatry.v19i3.953.

Full text

Abstract:

<div style="left: 70.8662px; top: 324.72px; font-size: 15.45px; font-family: serif; transform: scaleX(0.971046);" data-canvas-width="419.81549999999993">According to epidemiological studies, rates of social anxiety disorder</div><div style="left: 70.8662px; top: 344.72px; font-size: 15.45px; font-family: serif; transform: scaleX(1.11655);" data-canvas-width="424.26750000000004">(SAD) or social phobia range from 3% to 16% in the general</div><div style="left: 70.8662px; top: 364.72px; font-size: 15.45px; font-family: serif; transform: scaleX(0.987995);" data-canvas-width="69.1185">population.</div><div style="left: 139.985px; top: 365.947px; font-size: 9.00733px; font-family: serif; transform: scaleX(0.952064);" data-canvas-width="16.423109999999998">[1,2]</div><div style="left: 156.408px; top: 364.72px; font-size: 15.45px; font-family: serif; transform: scaleX(0.977187);" data-canvas-width="334.422">Social phobia and specific phobias have an earlier age</div>of onset than other anxiety disorders.

APA, Harvard, Vancouver, ISO, and other styles

3

Muller, Jacqueline E., Liezl Koen, Soraya Seedat, and Dan J. Stein. "Social Anxiety Disorder." CNS Drugs 19, no. 5 (2005): 377–91. http://dx.doi.org/10.2165/00023210-200519050-00002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Zakri, Hani. "Social anxiety disorder." InnovAiT: Education and inspiration for general practice 8, no. 11 (September 22, 2015): 677–84. http://dx.doi.org/10.1177/1755738015601449.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Kaminer, Debra, and Dan J. Stein. "Social anxiety disorder." World Journal of Biological Psychiatry 4, no. 3 (January 2003): 103–10. http://dx.doi.org/10.1080/15622970310029902.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Schneier, Franklin R. "Social Anxiety Disorder." New England Journal of Medicine 355, no. 10 (September 7, 2006): 1029–36. http://dx.doi.org/10.1056/nejmcp060145.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Leichsenring, Falk, and Frank Leweke. "Social Anxiety Disorder." New England Journal of Medicine 376, no. 23 (June 8, 2017): 2255–64. http://dx.doi.org/10.1056/nejmcp1614701.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Schneier, F. R. "Social anxiety disorder." BMJ 327, no. 7414 (September 6, 2003): 515–16. http://dx.doi.org/10.1136/bmj.327.7414.515.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Swinson, Richard P. "Social Anxiety Disorder." Canadian Journal of Psychiatry 50, no. 6 (May 2005): 305–7. http://dx.doi.org/10.1177/070674370505000601.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Stein, Murray B., and Dan J. Stein. "Social anxiety disorder." Lancet 371, no. 9618 (March 2008): 1115–25. http://dx.doi.org/10.1016/s0140-6736(08)60488-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Raj, B. Ashok, and David V. Sheehan. "SOCIAL ANXIETY DISORDER." Medical Clinics of North America 85, no. 3 (May 2001): 711–33. http://dx.doi.org/10.1016/s0025-7125(05)70337-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Stein, Murray B. "Social Anxiety Disorder." CNS Spectrums 4, no. 11 (November 1999): 17. http://dx.doi.org/10.1017/s1092852900012451.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Szuhany, Kristin L., and Naomi M. Simon. "Anxiety Disorders." JAMA 328, no. 24 (December 27, 2022): 2431. http://dx.doi.org/10.1001/jama.2022.22744.

Full text

Abstract:

ImportanceAnxiety disorders have a lifetime prevalence of approximately 34% in the US, are often chronic, and significantly impair quality of life and functioning.ObservationsAnxiety disorders are characterized by symptoms that include worry, social and performance fears, unexpected and/or triggered panic attacks, anticipatory anxiety, and avoidance behaviors. Generalized anxiety disorder (6.2% lifetime prevalence), social anxiety disorder (13% lifetime prevalence), and panic disorder (5.2% lifetime prevalence) with or without agoraphobia are common anxiety disorders seen in primary care. Anxiety disorders are associated with physical symptoms, such as palpitations, shortness of breath, and dizziness. Brief screening measures applied in primary care, such as the Generalized Anxiety Disorder–7, can aid in diagnosis of anxiety disorders (sensitivity, 57.6% to 93.9%; specificity, 61% to 97%). Providing information about symptoms, diagnosis, and evidence-based treatments is a first step in helping patients with anxiety. First-line treatments include pharmacotherapy and psychotherapy. Selective serotonin reuptake inhibitors (SSRIs, eg, sertraline) and serotonin-norepinephrine reuptake inhibitors (SNRIs, eg, venlafaxine extended release) remain first-line pharmacotherapy for generalized anxiety disorder, social anxiety disorder, and panic disorder. Meta-analyses suggest that SSRIs and SNRIs are associated with small to medium effect sizes compared with placebo (eg, generalized anxiety disorder: standardized mean difference [SMD], −0.55 [95% CI, −0.64 to −0.46]; social anxiety disorder: SMD, −0.67 [95% CI, −0.76 to −0.58]; panic disorder: SMD, −0.30 [95% CI, −0.37 to −0.23]). Cognitive behavioral therapy is the psychotherapy with the most evidence of efficacy for anxiety disorders compared with psychological or pill placebo (eg, generalized anxiety disorder: Hedges g = 1.01 [large effect size] [95% CI, 0.44 to 1.57]; social anxiety disorder: Hedges g = 0.41 [small to medium effect] [95% CI, 0.25 to 0.57]; panic disorder: Hedges g = 0.39 [small to medium effect[ [95% CI, 0.12 to 0.65]), including in primary care. When selecting treatment, clinicians should consider patient preference, current and prior treatments, medical and psychiatric comorbid illnesses, age, sex, and reproductive planning, as well as cost and access to care.Conclusions and RelevanceAnxiety disorders affect approximately 34% of adults during their lifetime in the US and are associated with significant distress and impairment. First-line treatments for anxiety disorders include cognitive behavioral therapy, SSRIs such as sertraline, and SNRIs such as venlafaxine extended release.

APA, Harvard, Vancouver, ISO, and other styles

14

Van Ameringen, Michael, and Beth Patterson. "Refractory social anxiety disorder." Journal of Psychiatry & Neuroscience 42, no. 1 (January 1, 2017): E1—E2. http://dx.doi.org/10.1503/jpn.160016.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Berber, Mark. "Recognizing Social Anxiety Disorder." Canadian Journal of Psychiatry 49, no. 9 (September 2004): 645. http://dx.doi.org/10.1177/070674370404900921.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Leon, Andrew C., Laura Portera, and Myrna M. Weissman. "The Social Costs of Anxiety Disorders." British Journal of Psychiatry 166, S27 (April 1995): 19–22. http://dx.doi.org/10.1192/s0007125000293355.

Full text

Abstract:

Background. The social costs of anxiety disorders, which afflict a substantial proportion of the general population in the United States, are considered.Method. Data from the National Institute of Mental Health (NIMH) Epidemiological Catchment Area Program were analysed.Results. Over 6% of men and 13% of women in the sample of 18 571 had suffered from a DSM–III anxiety disorder in the past six months. Nearly 30% of those with panic disorder had used the general medical system for emotional, alcohol or drug-related problems in the six months prior to the interview. Those with anxiety disorders were also more likely to seek help from emergency rooms and from the specialised mental health system. Men with panic disorder, phobias or obsessive–compulsive disorder in the previous six months are more likely to be chronically unemployed and to receive disability or welfare.Discussion. Once correctly diagnosed there are safe and effective psychopharmacologic and behavioural treatments for the anxiety disorders. Nevertheless the burden of anxiety disorders extends beyond the direct costs of treatment to the indirect costs of impaired social functioning.

APA, Harvard, Vancouver, ISO, and other styles

17

Avramchuk, Oleksandr. "Social anxiety disorder: relevance and perspectives." Psychosomatic Medicine and General Practice 3, no. 3 (September 10, 2018): e0303103. http://dx.doi.org/10.26766/pmgp.v3i3.103.

Full text

Abstract:

Background Epidemiological studies indicate that social anxiety disorder as one of the most common mental health disorders. However, many patients do not seek or receive help, despite the prevalence of social anxiety disorder, the large amount of information, the possibilities of psychotherapy and medical treatment Aim Generalization of actual knowledge and research on the aetiology and pathogenetic mechanisms of social phobias and coverage of the actual issues of low referral of people suffering from social phobia Methods For review, the following databases, such as ScienceDirect, ResearchGate, PubMed and Google Scholar, were used. The search was performed using the keywords: social anxiety disorder, sociophobia, social anxiety, cognitive-behavioral model, neurobiology, mental health Results The general information about social anxiety disorder, its prevalence and its consequences were covered. The main etiological mechanisms, modern views on the neurobiological and psychological basis of the disorder are considered. In addition, the peculiarities of the clinical picture and its influence on the social functioning of the individual, including the referral of help, were analyzed. The aspects that are useful to consider during the development of recommendations for specialists in general medical practice and centers of public mental health were suggested Conclusions A social anxiety disorder should be considered as a complex mental health disorder. Recognition of signs of social anxiety disorder in their component often leads to a false interpretation of clinical signs as manifestations of depression or other neurotic disorders among primary care professionals. Informing general practitioners and specialists of public mental health centers about the traits of the clinical picture and the social functioning of patients with this disorder can help to overcome the stigma and improve the referral of qualified assistance

APA, Harvard, Vancouver, ISO, and other styles

18

Hofmann, Stefan G., M. A. Anu Asnaani, and Devon E. Hinton. "Cultural aspects in social anxiety and social anxiety disorder." Depression and Anxiety 27, no. 12 (December 2010): 1117–27. http://dx.doi.org/10.1002/da.20759.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Isolan, Luciano Rassier, Cristian Patrick Zeni, Kelin Mezzomo, Carolina Blaya, Leticia Kipper, Elizeth Heldt, and Gisele Gus Manfro. "Behaviorial inhibition and history of childhood anxiety disorders in Brazilian adult patients with panic disorder and social anxiety disorder." Revista Brasileira de Psiquiatria 27, no. 2 (June 2005): 97–100. http://dx.doi.org/10.1590/s1516-44462005000200005.

Full text

Abstract:

PURPOSE: To evaluate the presence of behavioral inhibition and anxiety disorders during childhood in Brazilian adult patients with panic disorder and social anxiety disorder compared to a control group. METHODS: Fifty patients with panic disorder, 50 patients with social anxiety disorder, and 50 control subjects were included in the study. To assess the history of childhood anxiety, the Schedule for Affective Disorders and Schizophrenia for School Age Children, Epidemiologic Version (K-SADS-E), and the Diagnostic Interview for Children and Adolescents-Parent Version (DICA-P) were used. The presence of behavioral inhibition in childhood was assessed by the self-reported scale of Behavioral Inhibition Retrospective Version (RSRI-30). RESULTS: Patients showed significantly higher prevalence of anxiety disorders and behavioral inhibition in childhood compared to the control group. Patients with social anxiety disorder also showed significantly higher rates of avoidance disorder (46% vs. 18%, p = 0.005), social anxiety disorder (60% vs. 26%, p = 0.001), presence of at least one anxiety disorder (82% vs. 56%, p = 0.009) and global behavioral inhibition (2.89 ± 0.61 vs. 2.46 ± 0.61, p < 0.05) and school/social behavioral inhibition (3.56 ± 0.91 vs. 2.67 ± 0.82, p < 0.05) in childhood compared to patients with panic disorder. CONCLUSION: Our data are in accordance to the literature and corroborates the theory of an anxiety diathesis, suggesting that a history of anxiety disorders in childhood is associated with an anxiety disorder diagnosis, mainly social anxiety disorder, in adulthood.

APA, Harvard, Vancouver, ISO, and other styles

20

Kajitani, Kosuke, Rikako Tsuchimoto, Yusaku Omodaka, Tomoko Matsushita, Hideaki Fukumori, Takeshi Sato, and Jun Nagano. "Neurodevelopmental Disorder Traits in Taijin-Kyofu-sho and Social Anxiety Disorder: A Cross-Sectional Study among University Students." Psychiatry Journal 2021 (September 17, 2021): 1–9. http://dx.doi.org/10.1155/2021/1661617.

Full text

Abstract:

Taijin-Kyofu-sho is an East Asian culture-bound anxiety disorder with similarities to social anxiety disorder. However, few studies have examined these two disorders from the perspective of neurodevelopmental disorders. This study is aimed at examining the association of Taijin-Kyofu-sho and social anxiety disorder with the attention-deficit/hyperactivity disorder (ADHD) trait and autism spectrum disorder (ASD) trait. The Liebowitz Social Anxiety, Taijin-Kyofu-sho, and Adult Attention-Deficit/Hyperactivity Disorder Self-Report scales and the 16-item Autism-Spectrum Quotient were administered to 818 university students. Participants were divided into four groups: control (neither Taijin-Kyofu-sho nor social anxiety disorder), pure Taijin-Kyofu-sho (Taijin-Kyofu-sho alone), pure social anxiety disorder (social anxiety disorder alone), and mixed Taijin-Kyofu-sho-social anxiety disorder (both Taijin-Kyofu-sho and social anxiety disorder). We used logistic regression analysis to examine whether the ADHD trait and ASD trait were associated with Taijin-Kyofu-sho and social anxiety disorder. ASD trait was significantly associated with pure Taijin-Kyofu-sho ( p = 0.006 , odds ratio: 3.99). Female sex and ADHD trait were significantly associated with pure social anxiety disorder (sex: p = 0.013 , odds ratio: 2.61; ADHD trait: p = 0.012 , odds ratio: 2.46). Female sex, ADHD trait, and ASD trait were significantly associated with mixed Taijin-Kyofu-sho-social anxiety disorder (sex: p = 0.043 , odds ratio: 2.16; ADHD trait: p = 0.003 , odds ratio: 2.75; ASD trait: p < 0.001 , odds ratio: 16.93). Neurodevelopmental disorder traits differed between individuals with Taijin-Kyofu-sho and those with social anxiety disorder. Overall, our study reveals that Japanese individuals with the ADHD or ASD traits are at a heightened risk of developing Taijin-Kyofu-sho or social anxiety disorder.

APA, Harvard, Vancouver, ISO, and other styles

21

Avramchuk, Oleksandr. "Social phobia: relevance and perspectives." Psychosomatic Medicine and General Practice 4, no. 1 (April 12, 2019): e0401151. http://dx.doi.org/10.26766/pmgp.v4i1.151.

Full text

Abstract:

Background Epidemiological studies indicate that social anxiety disorder is one of the most common mental health disorders. However, despite the prevalence of social anxiety disorder, a large amount of information, the possibilities of psychotherapy and medical treatment, many patients for various reasons do not receive or do not seek help. Aim Generalization of actual knowledge and research on the aetiology and pathogenetic mechanisms of social phobias and coverage of the actual issues of low referral of people suffering from social phobia Methods For review, the following databases, such as ScienceDirect, ResearchGate, PubMed and Google Scholar, were used. The search was performed using the keywords: social anxiety disorder, sociophobia, social anxiety, cognitive-behavioral model, neurobiology, mental health. Results The general information about social anxiety disorder, its prevalence and its consequences were covered. The main etiological mechanisms, modern views on the neurobiological and psychological basis of the disorder are considered. In addition, the peculiarities of the clinical picture and its influence on the social functioning of the individual, including the referral of help, were analyzed. The aspects that are useful to consider during the development of recommendations for specialists in general medical practice and centers of public mental health were suggested. Conclusion A social anxiety disorder should be considered as a complex mental health disorder. Recognition of signs of social anxiety disorder in their component often leads to a false interpretation of clinical signs as manifestations of depression or other neurotic disorders among primary care professionals. Informing general practitioners and specialists of public mental health centers about the traits of the clinical picture and the social functioning of patients with this disorder can help to overcome the stigma and improve the referral of qualified assistance.

APA, Harvard, Vancouver, ISO, and other styles

22

Erwin, Brigette A., Richard G. Heimberg, Harlan Juster, and Melissa Mindlin. "Comorbid anxiety and mood disorders among persons with social anxiety disorder." Behaviour Research and Therapy 40, no. 1 (January 2002): 19–35. http://dx.doi.org/10.1016/s0005-7967(00)00114-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

LaFreniere, Peter. "A functionalist perspective on social anxiety and avoidant personality disorder." Development and Psychopathology 21, no. 4 (October 14, 2009): 1065–82. http://dx.doi.org/10.1017/s0954579409990046.

Full text

Abstract:

AbstractA developmental–evolutionary perspective is used to synthesize basic research from the neurosciences, ethology, genetics, and developmental psychology into a unified framework for understanding the nature and origins of social anxiety and avoidant personality disorder. Evidence is presented that social anxiety disorder (social phobia) and avoidant personality disorder may be alternate conceptualizations of the same disorder because they have virtually the same symptoms and genetic basis, and respond to the same pharmacologic and psychotherapeutic interventions. A functionalist perspective on social anxiety is formulated to (a) explain the origins of normative states of anxiety, (b) outline developmental pathways in the transition from normative anxiety to social anxiety and avoidant personality disorders, and (c) account for the processes leading to gender-differentiated patterns of anxiety-related disorders after puberty.

APA, Harvard, Vancouver, ISO, and other styles

24

Manfro, Gisele Gus, Luciano Isolan, Carolina Blaya, Sandra Maltz, Elizeth Heldt, and Mark H. Pollack. "Relationship between adult social phobia and childhood anxiety." Revista Brasileira de Psiquiatria 25, no. 2 (June 2003): 96–99. http://dx.doi.org/10.1590/s1516-44462003000200009.

Full text

Abstract:

OBJECTIVE: The aim of this study was to evaluate the prevalence of traumas and the presence of childhood anxiety disorders in adult patients with social phobia and investigate their influence on the presentation of the disorder. METHODS: Twenty-four adult patients with social phobia were asked about the presence of trauma before the age of 16. The K-SADS-E and the DICA-P interviews were used to assess these patients regarding childhood anxiety disorders. RESULTS: Twelve (50%) patients reported a history of trauma before the age of 16. The presence of trauma did not influence the presentation of the disorder. Seventy-five percent of patients had a history of anxiety disorders in childhood. Patients with a history of at least 2 childhood anxiety disorders had an increased lifetime prevalence of major depression (10 vs. 3; p=.04) and family history of psychiatric disorders (13 vs. 6; p=.02). CONCLUSION: Anxiety disorder in childhood is associated with family history of psychiatric disorders. The presence of more than one diagnosis of anxiety disorder in childhood can be considered a risk factor for the development of depression in adult patients with social phobia.

APA, Harvard, Vancouver, ISO, and other styles

25

Garcia de Miguel, Berta, David J. Nutt, Sean D. Hood, and Simon JC Davies. "Elucidation of neurobiology of anxiety disorders in children through pharmacological challenge tests and cortisol measurements: a systematic review." Journal of Psychopharmacology 26, no. 4 (July 19, 2010): 431–42. http://dx.doi.org/10.1177/0269881110372818.

Full text

Abstract:

Anxiety disorders are common both in adults and children. While there have been major advances in understanding the neurobiology of anxiety disorders in adults, progress has been more limited in the elucidation of the mechanisms underlying these disorders in childhood. There is a need to delineate childhood biological models, since anxiety represents a significant clinical problem in children and is a risk factor for the subsequent development of anxiety and depression in adulthood. We conducted a review of the literature regarding pharmacological challenge tests and direct hypothalamic–pituitary–adrenal axis measurement in children with anxiety disorders, with emphasis on panic disorder and social anxiety disorder. Studies identified were contrasted with those in adult panic disorder and social anxiety disorder. Despite this broad approach few studies emerged in children, with only 22 studies meeting inclusion criteria. When contrasted with adult neurobiological models of panic disorder and social anxiety disorder, children studied showed some abnormalities which mirrored those reported in adults, such as altered baseline respiration, altered responses to CO2 challenge tests and blunted growth hormone response to yohimbine. However, results differed from adults with panic disorder and social anxiety in some aspects of noradrenergic and serotonergic function. For endpoints studied in panic disorder children, unlike adults, displayed a lack of baseline end-tidal CO2 abnormalities and a different hypothalamic–pituitary–adrenal pattern response under low-dose CO2. The biology of these anxiety disorders in children may only partially mirror that of adult anxiety disorders. However, caution is required as the evidence is limited, and many studies combined patients with panic disorder and social anxiety disorder with other disorders or non-specific anxiety. Further research is required to fully understand the biology and progression of childhood anxiety disorders.

APA, Harvard, Vancouver, ISO, and other styles

26

Goodman, Fallon R., Todd B. Kashdan, Melissa C. Stiksma, and Dan V. Blalock. "Personal Strivings to Understand Anxiety Disorders: Social Anxiety as an Exemplar." Clinical Psychological Science 7, no. 2 (November 14, 2018): 283–301. http://dx.doi.org/10.1177/2167702618804778.

Full text

Abstract:

People with anxiety disorders tend to make decisions on the basis of avoiding threat rather than obtaining rewards. Despite a robust literature examining approach-avoidance motivation, less is known about goal pursuit. The present study examined the content, motives, consequences, and daily correlates of strivings among adults diagnosed with social anxiety disorder and healthy controls. Participants generated six strivings along with the motives and consequences of their pursuit. Compared with controls, people with social anxiety disorder were less strongly driven by autonomous motives and reported greater difficulty pursuing strivings. Coders analyzed strivings for the presence of 10 themes: achievement, affiliation, avoidance, emotion regulation, generativity, interpersonal, intimacy, power, self-presentation, and self-sufficiency. People with social anxiety disorder constructed more emotion regulation strivings than did controls, but they did not differ across other themes. This research illustrates how studying personality at different levels of analysis (traits, strivings) can yield novel information for understanding anxiety disorders.

APA, Harvard, Vancouver, ISO, and other styles

27

Robinson, Hayley M., Sean D. Hood, Caroline J. Bell, and David J. Nutt. "Dopamine and social anxiety disorder." Revista Brasileira de Psiquiatria 28, no. 4 (December 2006): 263–64. http://dx.doi.org/10.1590/s1516-44462006000400003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Sokolenko, Marina, and Stan Kutcher. "Sertraline for social anxiety disorder." Expert Review of Neurotherapeutics 3, no. 6 (November 2003): 787–95. http://dx.doi.org/10.1586/14737175.3.6.787.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Nardi, Antonio E. "Antidepressants in social anxiety disorder." Arquivos de Neuro-Psiquiatria 59, no. 3A (September 2001): 637–42. http://dx.doi.org/10.1590/s0004-282x2001000400032.

Full text

Abstract:

Social anxiety disorder (SAD) is a marked and persistent fear of doing almost everything in front of people due to concerns about being judge by others. An up-to-date review is needed in order to reach a practical judgement of all psychopharmacological data. Case reports, open and double-blind trials with SAD were described and commented upon from a clinical point of view. The MEDLINE system was searched from 1975 to 2001. The references from the selected papers were also used as a source. MAOIs (fenelzine, tranylcypromine), reversible monoamino oxidase-A inhibitors (moclobemide, brofaromine), SSRIs (paroxetine, sertraline, fluoxetine, fluvoxamine) and some other antidepressants (venlafaxine, nefazodone) have proven effective in several studies with various methodologies. The MAOIs have more serious adverse effects and the SSRIs have the best tolerance. SSRIs are efficacious and the first choice of treatment.

APA, Harvard, Vancouver, ISO, and other styles

30

Dias, Mafalda M. "Pharmacotherapy for Social Anxiety Disorder." Issues in Mental Health Nursing 39, no. 12 (October 29, 2018): 1047–48. http://dx.doi.org/10.1080/01612840.2018.1522186.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Lele, M., and A. Joglekar. "Escitalopram for social anxiety disorder." British Journal of Psychiatry 187, no. 3 (September 2005): 290–91. http://dx.doi.org/10.1192/bjp.187.3.290-a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Davidson, Jonathan R. T., Edna B. Foa, Kathryn M. Connor, and L. Erik Churchill. "Hyperhidrosis in social anxiety disorder." Progress in Neuro-Psychopharmacology and Biological Psychiatry 26, no. 7-8 (December 2002): 1327–31. http://dx.doi.org/10.1016/s0278-5846(02)00297-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Blanco, Carlos, Smita X. Antia, and Michael R. Liebowitz. "Pharmacotherapy of social anxiety disorder." Biological Psychiatry 51, no. 1 (January 2002): 109–20. http://dx.doi.org/10.1016/s0006-3223(01)01294-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

den Boer, J. A., F. J. Bosker, and B. R. Slaap. "Neurobiology of social anxiety disorder." European Neuropsychopharmacology 9 (September 1999): 165–66. http://dx.doi.org/10.1016/s0924-977x(99)80049-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Schneier, Franklin R. "Pharmacotherapy of social anxiety disorder." Expert Opinion on Pharmacotherapy 12, no. 4 (January 18, 2011): 615–25. http://dx.doi.org/10.1517/14656566.2011.534983.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Davidson, Jonathan R. T. "Social anxiety disorder under scrutiny." Depression and Anxiety 11, no. 3 (2000): 93–98. http://dx.doi.org/10.1002/(sici)1520-6394(2000)11:3<93::aid-da2>3.0.co;2-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Dunlop, Boadie W., Laszlo Papp, Steven J. Garlow, Paul S. Weiss, Bettina T. Knight, and Philip T. Ninan. "Tiagabine for social anxiety disorder." Human Psychopharmacology: Clinical and Experimental 22, no. 4 (2007): 241–44. http://dx.doi.org/10.1002/hup.846.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Zhang, Qiyue. "Social Anxiety Disorder among Teenagers." Lecture Notes in Education Psychology and Public Media 7, no. 1 (May 17, 2023): 519–26. http://dx.doi.org/10.54254/2753-7048/7/2022910.

Full text

Abstract:

This paper aims to present the current understanding of social anxiety disorder among teenagers through reviewing the most relevant research and studies. To show the results and main findings, not only the impact that this disorder could have on individuals but also means of treatment will be illustrated. Social anxiety disorder has a serious impact on an adolescents mental and social wellness, making them too frustrated and afraid to function normally in society. This will also limit their performance in the long run because of the importance of cooperation and communication during study and work time. Treatment options for social anxiety disorder include both medication and non-pharmacological approaches, with each contributing to the recovery process. Drugs mainly work by balancing the chemicals in the brain, while non-drug therapies like cognitive behavioral therapy focus on stopping fear from a psychological perspective. Although studies have been conducted, a clear limitation is shown that not enough attention, by means of special treatment and early detection, is paid to teenagers. Future prevention and improvement should be made as soon as possible, and its essential to understand the importance of knowing the changing times. This paper can provide some references for future research. Everyone needs to try to create a more inclusive environment for patients, encouraging them to attend social events. Overall, its hoped that public awareness is raised about this topic.

APA, Harvard, Vancouver, ISO, and other styles

39

Hutchison, Taylor E., Alexander Murley Penney, and Jessica E. Crompton. "Procrastination and anxiety: Exploring the contributions of multiple anxiety-related disorders." Current Issues in Personality Psychology 6, no. 2 (March 16, 2018): 122–29. http://dx.doi.org/10.5114/cipp.2018.73054.

Full text

Abstract:

BackgroundProcrastination is the unnecessary delay of a task that subsequently creates anxiety (Rothblum, Solomon, & Maurakami, 1986). Research suggests that procrastination is linked with poorer mental health, but questions remain regarding its association with anxiety disorders. Studies exploring obsessive-compulsive disorder (OCD) and procrastination have found high levels of procrastination in OCD (Ferrari & McCown, 1994), but have also found no association between obsessive thoughts and procrastination (Kağan, Çakır, İlhan, & Kandemir, 2010). Scher and Osterman (2002) found that procrastination correlated with physiological anxiety and social anxiety, but not worry. No previous research has examined the connection between procrastination and health anxiety.Participants and procedureA non-clinical university sample (N = 300) completed online self-report questionnaires in order to examine the relationships between procrastination and symptoms of OCD, generalised anxiety disorder, social anxiety disorder, health anxiety, and panic disorder.ResultsSymptoms of panic disorder, social anxiety disorder, and health anxiety correlated with levels of procrastination. However, using a multiple regression analysis, only panic disorder symptoms uniquely predicted procrastination.ConclusionsIt is proposed that people with panic disorder may procrastinate to avoid anxiety inducing situations, or that individuals who frequently procrastinate may become sensitive to the anxiety caused by procrastination, thereby potentially triggering panic disorder. The full implications of these findings are further discussed.

APA, Harvard, Vancouver, ISO, and other styles

40

Batkholdina, S. R., and M. A. Asimov. "Influence of personal anxiety on the development of the eating disorders." Eurasian Journal of Current Research in Psychology and Pedagogy, no. 4 (January 16, 2024): 26–31. http://dx.doi.org/10.46914/2959-3999-2023-1-4-26-31.

Full text

Abstract:

The article is devoted to the study of the theoretical aspect of the influence of personality anxiety on the development of eating disorders. It is known that eating disorders such as anorexia nervosa, bulimia nervosa or paroxysmal overeating are very often comorbid with other mental disorders. These disorders may include (but are not limited to) depression, generalized anxiety disorder, social anxiety disorder, post-traumatic stress disorder, and obsessive-compulsive disorder. As we can see from the list, most often anxiety goes hand in hand with eating disorders, which is expressed in generalized anxiety disorder, social anxiety disorder and to some extent obsessive-compulsive disorder. Despite the fact that many scientific studies have been conducted to prove this relationship, many of them suffer from methodological problems that limit the usefulness of the results obtained.

APA, Harvard, Vancouver, ISO, and other styles

41

Afshari, Behrooz. "Personality and anxiety disorders: examination of revised reinforcement sensitivity theory in clinical generalized anxiety disorder, social anxiety disorder, and panic disorder." Current Issues in Personality Psychology 8, no. 1 (2020): 52–60. http://dx.doi.org/10.5114/cipp.2020.95148.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Akechi, Tatsuo, Toru Okuyama, Ryuichi Sagawa, Megumi Uchida, Tomohiro Nakaguchi, Yoshinori Ito, and Toshiaki A. Furukawa. "Social anxiety disorder as a hidden psychiatric comorbidity among cancer patients." Palliative and Supportive Care 9, no. 1 (February 25, 2011): 103–5. http://dx.doi.org/10.1017/s1478951510000581.

Full text

Abstract:

AbstractObjective:Social anxiety disorder is one of the most popular psychiatric disorders in the general population and is also well known as a very common comorbid psychiatric disorder among patients with major depression. On the other hand, social anxiety disorder has been termed “the neglected anxiety disorder” because its diagnosis is often missed. Furthermore, the potential impact of social anxiety disorder on the psychological distress of cancer patients has not been reported.Method:We encountered two cancer patients with refractory depression after cancer diagnosis, in whom comorbid social anxiety disorder was unexpectedly detected during a subsequent follow-up.Results:To the best of our knowledge, this is the first report to discuss the potential impact of social anxiety disorder on cancer patients' distress. These two cases may help to improve our understanding of the complicated mental health problems of cancer patients and the potential influence of social anxiety disorder on patients' follow-up medical treatment.Significance of results:Comorbid social anxiety disorder should be considered when a cancer patient's depression is resistant to treatment and the existence of communication problems between the patient and the medical staff is suspected.

APA, Harvard, Vancouver, ISO, and other styles

43

Lochner, Christine, Modise Mogotsi, Pieter L. du Toit, Debra Kaminer, Dana J. Niehaus, and Dan J. Stein. "Quality of Life in Anxiety Disorders: A Comparison of Obsessive-Compulsive Disorder, Social Anxiety Disorder, and Panic Disorder." Psychopathology 36, no. 5 (2003): 255–62. http://dx.doi.org/10.1159/000073451.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Alkozei, Anna, Cathy Creswell, Peter J. Cooper, and John J. B. Allen. "Autonomic arousal in childhood anxiety disorders: Associations with state anxiety and social anxiety disorder." Journal of Affective Disorders 175 (April 2015): 25–33. http://dx.doi.org/10.1016/j.jad.2014.11.056.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Baldwin, David, Julio Bobes, Dan J. Stein, Ingebor Scharwächter, and Michel Faure. "Paroxetine in social phobia/social anxiety disorder." British Journal of Psychiatry 175, no. 2 (August 1999): 120–26. http://dx.doi.org/10.1192/bjp.175.2.120.

Full text

Abstract:

BackgroundPreliminary studies have suggested that paroxetine may be effective in social phobia/social anxiety disorder.AimsTo assess the efficacy and tolerability of paroxetine in the acute (12-week) treatment of social phobia.MethodTwo-hundred and ninety patients with social phobia were assigned randomly to paroxetine (20–50 mg/day flexible dose) or placebo for 12 weeks of double-blind treatment. Primary efficacy outcomes were the Liebowitz Social Anxiety Scale (LSAS) total score (patient-rated) and the Clinical Global Impression (GGI) scale global improvement item. The secondary efficacy variables included CGI scale severity of illness score and the patient-rated Social Avoidance and Distress Scale.ResultsParoxetine produced a significantly greater reduction in LSAS total score (mean change from baseline: –29.4 v. –15.6; P 0.001) and a greater proportion of responders (score $2 on CGI global improvement) (65.7% v. 32.4%; P < 0.001) compared with placebo at the end of the 12-week study period. Both primary efficacy variables were statistically significant compared with placebo from week 4 onwards. Paroxetine was generally well tolerated.ConclusionsParoxetine is an effective, well-tolerated treatment for patients with social phobia.

APA, Harvard, Vancouver, ISO, and other styles

46

Romano, Mia, David A. Moscovitch, Ruofan Ma, and Jonathan D. Huppert. "Social problem solving in social anxiety disorder." Journal of Anxiety Disorders 68 (December 2019): 102152. http://dx.doi.org/10.1016/j.janxdis.2019.102152.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Schneier, Franklin R. "Paroxetine in social phobia/social anxiety disorder." Current Psychiatry Reports 2, no. 4 (July 2000): 326. http://dx.doi.org/10.1007/s11920-000-0076-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Su, Xinzi. "Influence of Social Media and Family Environment on Adolescent Anxiety Disorder." Journal of Education, Humanities and Social Sciences 22 (November 26, 2023): 207–13. http://dx.doi.org/10.54097/ehss.v22i.12421.

Full text

Abstract:

Adolescent anxiety disorder is a prevalent psychological disorder that has a substantial impact on the mental health and total development of adolescents. This study reviews and investigates the definition, characteristics, and the two essential etiological components of anxiety disorders in adolescents, namely social media and home environment. This is achieved by describing and analyzing prior research pertaining to anxiety disorders and adolescent mental health. The paper begins by defining adolescent anxiety disorder, noting that it is primarily characterized by excessive concern and tension, which is frequently accompanied by physical discomfort and emotional distress. Adolescents may exhibit social distress, avoidance behaviors, and academic difficulties that impair their daily functioning and learning. As a significant aspect of adolescents' existence, social media has a significant effect on their anxiety levels. Social anxiety, body image anxiety, and other stressors brought on by social media may aggravate anxiety symptoms. Moreover, online violence and negative remarks may have a negative effect on adolescents' mental health. Another crucial etiologic factor is the family environment. Instability, conflict, and tension in the home may increase the risk of adolescents developing anxiety disorders. Anxiety disorders have also been linked to parental styles and economic circumstances. Although numerous scientific studies have been conducted on adolescents and anxiety disorders, additional research is required to shed light on the progression of mental health disorders in adolescents and bring them to the attention of society.

APA, Harvard, Vancouver, ISO, and other styles

49

Özdemir, İlker, and Erkan Kuru. "Investigation of Cognitive Distortions in Panic Disorder, Generalized Anxiety Disorder and Social Anxiety Disorder." Journal of Clinical Medicine 12, no. 19 (October 3, 2023): 6351. http://dx.doi.org/10.3390/jcm12196351.

Full text

Abstract:

The aim of this study was to determine the main cognitive distortions observed in panic disorder (PD), generalized anxiety disorder (GAD) and social anxiety disorder (SAD) and to investigate the impact of cognitive distortions on diagnoses, depression levels, disorder type and severity of anxiety. This study consisted of 150 clinical (50 PD, 50 GAD, 50 SAD) and 91 healthy control participants. A sociodemographic data form, the Beck Depression Inventory (BDI), the Dysfunctional Attitudes Scale (DAS), the Cognitive Distortions Scale (CDS) and the State-Trait Anxiety Inventory (STAI) scales were administered to all participants. It was found that cognitive distortions were higher in individuals with PD, GAD and SAD. The PD, SAD and GAD groups were similar for “catastrophizing”, “mindreading”, “all or nothing thinking”, “overgeneralization”, “should statements” and “emotional reasoning”. “Personalization”, “labeling” and “minimizing or disqualifying the positive” were observed at a higher severity in the SAD group compared to the PD group, and “mental filter” was observed at a higher severity in the GAD group compared to the PD group. Our findings emphasize the need to address cognitive distortions in PD, GAD and SAD treatment. The evaluation of cognitive distortions specific to anxiety disorders is significant in guiding therapy goals and pioneering new research.

APA, Harvard, Vancouver, ISO, and other styles

50

Tung, Esther S., and Timothy A. Brown. "Distinct Risk Profiles in Social Anxiety Disorder." Clinical Psychological Science 8, no. 3 (April 28, 2020): 477–90. http://dx.doi.org/10.1177/2167702620901536.

Full text

Abstract:

Using a factor mixture model (FMM) approach, we examined whether social anxiety disorder (SAD) could be subtyped by distinct risk profiles and whether these subtypes predicted different manifestations of the disorder. We derived risk profiles from neurotic temperament (NT), positive temperament (PT), and autonomic arousability (AA), which are hypothesized to be important in the maintenance of anxiety disorders such as SAD. In our sample of 758 SAD outpatients, a two-class FMM solution fit the data best. Class 1 was characterized by very low PT, whereas PT in Class 2 was substantially higher. The two classes differed to a lesser extent on NT but were virtually equivalent on AA. Class 1 had significantly more men and individuals with depressive disorders, generalized SAD, and higher SAD severity. Class 2 had more individuals with performance subtype SAD. These findings provide initial support for distinct risk profiles within SAD that may be predictive of its clinical expression.

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!